Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Myelodysplastic Syndrome

  • Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients
    March 8, 2009

    Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients

    Dr. C H Weaver MD
  • Prolonged Erythropoietin Appears More Effective Than Short Course for MDS
    March 8, 2009

    Prolonged Erythropoietin Appears More Effective Than Short Course for MDS

    Dr. C H Weaver MD
  • Vidaza® Effective for High-risk Myelodysplastic Syndromes
    March 8, 2009

    Vidaza® Effective for High-risk Myelodysplastic Syndromes

    Dr. C H Weaver MD
  • Revlimid® Shows Promise for Myelodysplastic Syndromes
    November 13, 2007

    Revlimid® Shows Promise for Myelodysplastic Syndromes

    Dr. C H Weaver MD
  • Thalidomide Promising for Myelodysplastic Syndromes
    October 24, 2006

    Thalidomide Promising for Myelodysplastic Syndromes

    Dr. C H Weaver MD
Previous Page
1 2 3 4
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...